Compare · BBLG vs MAS
BBLG vs MAS
Side-by-side comparison of Bone Biologics Corp (BBLG) and Masco Corporation (MAS): market cap, price performance, sector, and recent activity on the wire.
Summary
- BBLG operates in Health Care, while MAS operates in Industrials - the two are in different parts of the market.
- MAS is the larger of the two at $15.28B, about 715.8x BBLG ($21.3M).
- Over the past year, BBLG is down 66.1% and MAS is up 22.7% - MAS leads by 88.9 points.
- MAS has hit the wire 8 times in the past 4 weeks while BBLG has been quiet.
- MAS has more recent analyst coverage (25 ratings vs 0 for BBLG).
- Company
- Bone Biologics Corp
- Masco Corporation
- Price
- $1.40+0.72%
- $74.22-1.62%
- Market cap
- $21.3M
- $15.28B
- 1M return
- +21.74%
- +20.62%
- 1Y return
- -66.13%
- +22.74%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 25
Bone Biologics Corp
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Masco Corporation
Masco Corporation designs, manufactures, and distributes home improvement and building products in North America, Europe, and internationally. The company operates through two segments, Plumbing Products and Decorative Architectural Products. The Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing units, shower bases and enclosures, sinks, toilets, acrylic tubs, shower trays, spas, exercise pools, and fitness systems; brass, copper, and composite plumbing system components; connected water products; thermoplastic solutions, extruded plastic profiles, specialized fabrications, and PEX tubing products; and other non-decorative plumbing products. This segment provides its products under the DELTA, BRIZO, PEERLESS, HANSGROHE, AXOR, KRAUS, GINGER, NEWPORT BRASS, BRASSTECH, WALTEC, BRISTAN, HERITAGE, MIROLIN, HÃPPE, HOT SPRING, CALDERA, FREEFLOW SPAS, FANTASY SPAS, ENDLESS POOLS, BRASSCRAFT, PLUMB SHOP, COBRA, COBRA PRO, and MASTER PLUMBER brands. The Decorative Architectural Products segment offers paints, primers, specialty coatings, stains, and waterproofing products, as well as paint applicators and accessories; cabinet and door hardware, functional hardware, wall plates, hook and rail products, closet organization systems, and picture hanging accessories; decorative bath hardware, mirrors, and shower accessories and doors; and decorative indoor and outdoor lighting fixtures, ceiling fans, landscape lighting, and LED lighting systems. This segment provides its products under the BEHR, KILZ, WHIZZ, Elder & Jenks, LIBERTY, BRAINERD, FRANKLIN BRASS, KICHLER, and ÃLAN brands. It sells its products to the plumbing, heating, and hardware wholesalers; home centers and online retailers; hardware stores; electrical and landscape distributors; lighting showrooms; building supply outlets; and other mass merchandisers. Masco Corporation was founded in 1929 and is headquartered in Livonia, Michigan.
Latest BBLG
- Bone Biologics Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Bone Biologics Corp
- SEC Form 10-K filed by Bone Biologics Corp
- SEC Form 4 filed by Chief Financial Officer Walsh Deina H
- SEC Form 4 filed by Chief Executive Officer Frelick Jeff
- Bone Biologics Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
- Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
- SEC Form 10-Q filed by Bone Biologics Corp
- SEC Form S-8 filed by Bone Biologics Corp
Latest MAS
- SEC Form 10-Q filed by Masco Corporation
- Masco Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Masco Corporation Reports First Quarter 2026 Results
- Masco Corporation Announces Leadership Changes
- Masco Corporation filed SEC Form 8-K: Leadership Update
- Masco Corporation to Host Investor Day on May 13, 2026
- Masco upgraded by Evercore ISI with a new price target
- SEC Form DEF 14A filed by Masco Corporation
- SEC Form PRE 14A filed by Masco Corporation
- Masco Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits